Haddy F J
Department of Physiology, Uniformed Services University, Bethesda, MD 20814.
Cardiovasc Drugs Ther. 1990 Mar;4 Suppl 2:343-9. doi: 10.1007/BF02603174.
Sodium chloride has no clearly established local direct action on blood vessels to produce constriction; on the contrary, it has an immediate local indirect action via osmolality, which produces vasodilation. Thus in order to explain salt-induced hypertension, a delayed remote indirect vasoconstrictor action must be postulated. This indirect vasoconstrictor action is apparently the result of volume expansion. Acute volume expansion imparts three physiologic properties to the plasma; these are the ability to inhibit Na,K-ATPase and the Na-K pump, to cause natriuresis, and to sensitize blood vessels to vasoconstrictor agents. Similarly, low-renin, volume-expanded hypertension endows the plasma with the capacity to inhibit the Na,K-ATPase pump, to sensitize blood vessels to vasoconstrictor agents, and to raise blood pressure. These properties apparently result from a circulating digitalislike substance(s), perhaps derived from the hypothalamus and/or adrenals. We here review the considerable effort expended in identifying the agent or agents, and conclude that both steroidal and peptidic structure must be considered. Regardless of its structure, we hypothesize that when sodium excretion does not keep pace with sodium intake, its release leads to increased contractile activity of cardiac and vascular smooth muscle and hence hypertension. Inhibition of the Na-K pump increases the intracellular sodium concentration, particularly when superimposed on genetic- or aldosterone-induced increased sodium permeability, resulting in depolarization and increased calcium influx (vascular smooth muscle) or altered Na(+)-Ca2+ exchange and decreased calcium efflux (heart muscle). The increased intracellular calcium concentration then accounts for the increased contractile activity. Depolarization may also increase the sensitivity of vascular smooth muscle to vasoconstrictor agents such as norepinephrine.(ABSTRACT TRUNCATED AT 250 WORDS)
氯化钠对血管没有明确确立的局部直接作用以产生收缩;相反,它通过渗透压有立即的局部间接作用,这种作用会产生血管舒张。因此,为了解释盐诱导的高血压,必须假定存在延迟的远程间接血管收缩作用。这种间接血管收缩作用显然是容量扩张的结果。急性容量扩张赋予血浆三种生理特性;这些特性是抑制钠钾ATP酶和钠钾泵的能力、引起利钠作用以及使血管对血管收缩剂敏感。同样,低肾素、容量扩张性高血压赋予血浆抑制钠钾ATP酶泵的能力、使血管对血管收缩剂敏感的能力以及升高血压的能力。这些特性显然源于一种循环的类洋地黄物质,可能源自下丘脑和/或肾上腺。我们在此回顾了在鉴定这种物质或这些物质方面所付出的巨大努力,并得出结论,甾体和肽类结构都必须予以考虑。无论其结构如何,我们假设当钠排泄跟不上钠摄入时,其释放会导致心脏和血管平滑肌的收缩活性增加,从而导致高血压。抑制钠钾泵会增加细胞内钠浓度,特别是当叠加在遗传或醛固酮诱导的钠通透性增加时,会导致去极化和钙内流增加(血管平滑肌)或改变钠钙交换并减少钙外流(心肌)。细胞内钙浓度的增加随后解释了收缩活性的增加。去极化也可能增加血管平滑肌对去甲肾上腺素等血管收缩剂的敏感性。(摘要截短至250字)